Intellectual Property
Apr. 17, 1999
Judge Denies Genentech Motion For Mistrial Over News Stories
On the fourth day of Genentech's Protropin patent infringement trial, a federal judge rejected the biotech firm's request for a mistrial over remarks during opening statements about prior settlement negotiations and what the biotech firm's lawyers called prejudicial publicity.
&...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In